Bellus Labs, a New Jersey-based private label and custom formulation laboratory, is celebrating a decade of sustained growth. Founded in 2015 by chemist and CEO Kristina Cimo and her husband, Michael, ...
GSK has agreed to acquire Canada’s Bellus Health for around $2 billion, bolting on a late-stage drug candidate for chronic refractory cough. The $14.75-per-share deal will add P2X3 antagonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback